Welcome to the e-CCO Library!

Oncologic decisions in IBD surgery
Year: 2019
Source: 8th S-ECCO IBD Masterclass
Authors: Phillip Fleshner
Created: Tuesday, 28 May 2019, 3:32 PM
Colectomy, Ileo anal pouch procedure, Ileorectal anastomosis, Stoma, Laparoscopic surgery, Post operative complications, IBD-associated cancer, Colorectal cancer, UC colorectal cancer surveillance
Files: 1
Only medical treatment can solve the problem!
Year: 2019
Source: 8th S-ECCO IBD Masterclass
Authors: Julián Panés
Created: Tuesday, 28 May 2019, 3:32 PM
Crohn's disease, Anti-TNF agents, Vedolizumab, Ustekinumab
Files: 1
OP001: Whole genome sequencing and imputation in Inflammatory Bowel Disease identifies 26 novel loci and offers therapeutically-relevant mechanistic insights
Year: 2017
Source: ECCO'17 Barcelona
Authors: Moutsianas L.
Last Modified: Wednesday, 15 March 2017, 11:02 AM by Vesna Babaja
Genetic factors, Genetics, immunology
Files: 1
OP002: Epigenetic biomarkers to detect UC associated neoplasia: Results from phase I of the ENDCAP-C study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Iqbal T.
Last Modified: Wednesday, 15 March 2017, 1:35 PM by ECCO Administrator
Ulcerative colitis, UC colorectal cancer surveillance, Genetics
Files: 1
OP003: Increased risk of acute arterial events in young patients with severely active Inflammatory Bowel Disease: A nationwide French cohort study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Kirchgesner J.
Last Modified: Wednesday, 15 March 2017, 1:43 PM by ECCO Administrator
Thromboembolism, Other extraintestinal manifestations
Files: 1
OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomics
Year: 2018
Source: ECCO'18 Vienna
Authors: de Bruyn Magali
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP004: Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn‘s Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Allez M.
Last Modified: Wednesday, 15 March 2017, 1:48 PM by ECCO Administrator
Autologous stem cell transplantation, T cell
Files: 1
OP004: The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: García-Olmo, Damian
Created: Friday, 9 November 2018, 10:21 AM by Lindley Fritze
Ulcerative colitis , Genetics , Lymphocyte, T cell
OP005: The PROSIT cohort of infliximab biosimilar in IBD: A prolonged follow-up on the efficacy and safety across Italy
Year: 2017
Source: ECCO'17 Barcelona
Authors: Fiorino G.
Last Modified: Wednesday, 15 March 2017, 1:53 PM by ECCO Administrator
Anti drug antibodies, Anti-TNF agents, Infliximab, Biosimilars
Files: 1
OP006: Apremilast for active Ulcerative Colitis: A phase 2, randomised, double-blind, placebo-controlled induction study
Year: 2018
Source: ECCO'18 Vienna
Authors: Danese Silvio
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP006: Correlation of durability of response, serum trough concentrations and outcome parameters: Long-term follow-up of the Trough Concentration Adapted Infliximab Treatment (TAXIT) trial
Year: 2017
Source: ECCO'17 Barcelona
Authors: Pouillon L.
Last Modified: Wednesday, 15 March 2017, 1:55 PM by ECCO Administrator
Chron's disease, Ulcerative colitis, Anti TNF drug levels, Anti drug antibodies, Infliximab
Files: 1
OP007: A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Lawrance I.
Last Modified: Wednesday, 15 March 2017, 2:21 PM by ECCO Administrator
Tacrolimus, Proctitis
Files: 1
OP007: Detection of mucosal healing with a serum marker panel in adalimumab treated patients with Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: de Bruyn Magali
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP008: An innovative treatment for refractory perianal fistulas in Crohn’s Disease: Local micro reinjection of autologous fat and adipose derived stromal vascular fraction (ClinicalTrials. gov NCT02520843, Eudract: 2013-002602-31)
Year: 2017
Source: ECCO'17 Barcelona
Authors: Serrero M.
Last Modified: Wednesday, 15 March 2017, 2:24 PM by ECCO Administrator
Perenial fistulae, Perianal disease, Autologous stem cell transplantation
Files: 1
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn’s Disease: 52-week results of a phase III randomised controlled trial
Year: 2017
Source: ECCO'17 Barcelona
Authors: Panés J.
Last Modified: Wednesday, 15 March 2017, 2:43 PM by ECCO Administrator
Stem cell transplantation/therapy
Files: 1
OP010: Long term efficacy and safety of Ustekinumab for Crohn’s Disease: Results from IM-UNITI long-term extension through 2 years
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Last Modified: Wednesday, 15 March 2017, 2:45 PM by ECCO Administrator
Ustekinumab
Files: 1
OP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: Al Bakir Ibrahim
Created: Friday, 23 March 2018, 12:23 PM
Files: 1